Cargando…

Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?

This review article offers an outlook on the use of opioids as therapeutics for treating several diseases, including cancer and non-cancer pain, and focuses the analysis on the opportunity to target opioid receptors for treating opioid use disorder (OUD), drug withdrawal, and addiction. Unfortunatel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabanelli, Rita, Brogi, Simone, Calderone, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341731/ https://www.ncbi.nlm.nih.gov/pubmed/37446064 http://dx.doi.org/10.3390/ijms241310888

Ejemplares similares

Improving Curcumin Bioavailability: Current Strategies and Future Perspectives
por: Tabanelli, Rita, et al.
Publicado: (2021)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
por: Barra, Fabio, et al.
Publicado: (2019)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Cytokine removal in human septic shock: Where are we and where are we going?
por: Honore, Patrick M., et al.
Publicado: (2019)

Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)

Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
por: Németh, Tamás, et al.
Publicado: (2022)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021)

Colon Capsule Endoscopy: Where Are We and Where Are We Going
por: Han, Yoo Min, et al.
Publicado: (2016)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
por: Hayes, Gemma E., et al.
Publicado: (2016)

Accommodative intraocular lenses: where are we and where we are going
por: Alió, Jorge L., et al.
Publicado: (2017)

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
por: Alenazi, Aqeel M., et al.
Publicado: (2023)

Biomarkers of Neonatal Sepsis: Where We Are and Where We Are Going
por: Boscarino, Giovanni, et al.
Publicado: (2023)

PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
por: Giraudet, Anne-Laure, et al.
Publicado: (2021)

Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
por: do Carmo Silva, Lívia, et al.
Publicado: (2020)

Critical care - where have we been and where are we going?
por: Vincent, Jean-Louis
Publicado: (2013)

Male contraception: where are we going and where have we been?
por: Reynolds-Wright, John Joseph, et al.
Publicado: (2019)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Artificial Intelligence in Digestive Endoscopy—Where Are We and Where Are We Going?
por: Vulpoi, Radu-Alexandru, et al.
Publicado: (2022)

Alopecia Areata in Latin America: Where are We and Where are We Going?
por: Velásquez-Lopera, Margarita M., et al.
Publicado: (2022)

The peritumoral brain zone in glioblastoma: where we are and where we are going
por: Giambra, Martina, et al.
Publicado: (2022)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Where are we going?
por: Pawl, Ronald P.
Publicado: (2010)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
por: Buchsbaum, Rachel J., et al.
Publicado: (2016)

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
por: Turnbull, Samantha, et al.
Publicado: (2015)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017)

Hypothyroidism in Context: Where We’ve Been and Where We’re Going
por: Chiovato, Luca, et al.
Publicado: (2019)

Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
por: Chung, Wei-Hsin, et al.
Publicado: (2023)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Tumor Models and Drug Targeting In Vitro—Where Are We Today? Where Do We Go from Here?
por: Krüger, Marcus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_87r6k25cafsneivieum8mur98n